RSV cps2 Vaccine

N/A

Report date: 2022/12/06 18:25:36

Base Information

Drug NameRSV cps2 Vaccine

Drug Alias NameRespiratory syncytial virus vaccine cps2Recombinant live-attenuated respiratory syncytial virus vaccine - Medimmune/NIAIDRSV vaccine live-attenuated genetically stabilised - Medimmune/NIAIDrA2cp248/404-1030 Delta SH genetically stabilised

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Live attenuated vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsRespiratory Syncytial Virus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)Medimmune

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)

Active IndicationsN/A

Inactive IndicationsRespiratory Syncytial Virus Infections

Other Information

ATC CodeN/A